These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 26537683

  • 1. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
    Li Y, Long X, Huang L, Yang M, Yuan Y, Wang Y, Delecluse HJ, Kuang E.
    J Virol; 2016 Jan 15; 90(2):887-903. PubMed ID: 26537683
    [Abstract] [Full Text] [Related]

  • 2. BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.
    Long X, Li Y, Yang M, Huang L, Gong W, Kuang E.
    J Virol; 2016 Sep 01; 90(17):7880-93. PubMed ID: 27334596
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1.
    Morrison TE, Mauser A, Klingelhutz A, Kenney SC.
    J Virol; 2004 Jan 01; 78(1):544-9. PubMed ID: 14671137
    [Abstract] [Full Text] [Related]

  • 9. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
    Morrison TE, Kenney SC.
    Virology; 2004 Oct 25; 328(2):219-32. PubMed ID: 15464842
    [Abstract] [Full Text] [Related]

  • 10. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC.
    J Virol; 2013 Jan 25; 87(2):935-50. PubMed ID: 23135711
    [Abstract] [Full Text] [Related]

  • 11. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
    Robinson AR, Kwek SS, Kenney SC.
    PLoS Pathog; 2012 Feb 25; 8(2):e1002516. PubMed ID: 22346751
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
    Ellis-Connell AL, Iempridee T, Xu I, Mertz JE.
    J Virol; 2010 Oct 25; 84(19):10329-43. PubMed ID: 20668090
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R, Osborn K, Ramasubramanyan S, Perez-Fernandez IBN, Godfrey A, Mancini EJ, Sinclair AJ.
    J Gen Virol; 2018 Jun 25; 99(6):805-817. PubMed ID: 29580369
    [Abstract] [Full Text] [Related]

  • 15. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
    Kraus RJ, Yu X, Cordes BA, Sathiamoorthi S, Iempridee T, Nawandar DM, Ma S, Romero-Masters JC, McChesney KG, Lin Z, Makielski KR, Lee DL, Lambert PF, Johannsen EC, Kenney SC, Mertz JE.
    PLoS Pathog; 2017 Jun 25; 13(6):e1006404. PubMed ID: 28617871
    [Abstract] [Full Text] [Related]

  • 16. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.
    Hahn AM, Huye LE, Ning S, Webster-Cyriaque J, Pagano JS.
    J Virol; 2005 Aug 25; 79(15):10040-52. PubMed ID: 16014964
    [Abstract] [Full Text] [Related]

  • 17. Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.
    Fu W, Verma D, Burton A, Swaminathan S.
    J Virol; 2019 Feb 15; 93(4):. PubMed ID: 30541834
    [Abstract] [Full Text] [Related]

  • 18. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
    Siddiqi UZ, Vaidya AS, Li X, Marcon E, Tsao SW, Greenblatt J, Frappier L.
    J Virol; 2019 Oct 15; 93(20):. PubMed ID: 31341047
    [Abstract] [Full Text] [Related]

  • 19. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H, Zhao Y, Zeng L, Tang M, El-Deeb A, Li JJ, Cao Y.
    Anticancer Res; 2004 Oct 15; 24(1):67-74. PubMed ID: 15015577
    [Abstract] [Full Text] [Related]

  • 20. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S, Dolcetti R, Keppel S, Celeghin A, Indraccolo S, Dal Col J, Mastorci K, De Rossi A.
    Clin Cancer Res; 2013 Apr 15; 19(8):2036-47. PubMed ID: 23444223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.